Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.

Genetic testing - 1 Jan 1999

McConnell L M, Koenig B A, Greely H T, Raffin T A

Abstract excerpt

Several genes associated with Alzheimer disease (AD) have been localized and cloned; two genetic tests are already commercially available, and new tests are being developed. Genetic testing for AD--either for disease prediction or for diagnosis--raises critical ethical concerns. The multidisciplinary Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics, and Society (PGES) presents...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Ethics, Medical
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Source

Identifiers

PMID: 10464572
DOI: 10.1089/gte.1999.3.3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.PMID 10464572Read ↗

Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society.Semantic proximity Read ↗

Genetic testing for Alzheimer disease. Practical and ethical issues.Semantic proximity Read ↗

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Semantic proximity Read ↗

Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.Semantic proximity Read ↗

The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.Semantic proximity Read ↗

Genetics of Alzheimer's disease: From pathogenesis to clinical usage.Semantic proximity Read ↗

Advances in genetic testing for Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.Semantic proximity Read ↗

New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.Semantic proximity Read ↗

Ethical, Legal and Social Implications of Susceptibility Genetic Testing for Late-Onset Neurodegenerative DiseasesSemantic proximity Read ↗

Genetic testing and Alzheimer disease: the promise.Semantic proximity Read ↗

The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.